Rheumatoid Arthritis Therapeutic Renewal



Rheumatoid Arthritis Therapeutic Renewal
Rheumatoid Arthritis: Therapeutic
This very painful disease, with still mysterious causes, is treated better than the diagnosis is
early. With a background treatment established within three months after the onset of signs,
we can now obtain a remission of rheumatoid arthritis said Best Doctor for Rheumatoid
Arthritis. As with other chronic inflammatory diseases, the arrival of biotherapies has
completely changed the situation for a majority of patients.
This rheumatic disease affects 300,000 people in France and generally appears between 40
and 60 years, with a juvenile form that affects 3000 children. Rheumatoid arthritis is
characterized by inflammation of the synovial membrane of the limb joints, which can lead,
more or less rapidly, to the breakdown of bone and cartilage resulting in the need of Psoriatic
Arthritis Doctor.
Rheumatoid arthritis causes pain and swelling mainly in the joints of the hands and wrists,
symmetrically. These pains are particularly strong at night and in the morning; it takes at least
half an hour to "rustle" the affected joints. As soon as these signs appear, you must consult a
Doctor Specializes in Arthritis as quickly as possible in order to establish, in collaboration
with a specialist, the best intervention strategy. The diagnosis is based on clinical
examination of the joints and on biological analyzes. Radiological examinations can also be
performed to identify bone erosions.
Triggering factor
Rheumatoid arthritis is an autoimmune disease in which the immune system reacts against
certain modified proteins in the body. These changes are natural, they occur more frequently
in certain organs such as the lung, but in some cases that we still do not understand, the
immune system triggers a reaction against these molecules says Pain Specialist in New
York. The triggering factor is therefore still unclear, but some susceptibility genes seem to be
involved in 30% of cases.
Moreover, as three out of four cases are women around midlife, and therefore around the
menopause, hormones could play a role. Environmental factors have also been identified,
including tobacco, which plays a major role. A recent study has shown that, in patients with a
slightly favourable genetic profile for rheumatoid arthritis, those who avoid smoking have a
two-fold risk of seeing the disease develop.
It is also known that tobacco aggravates the disease that its development is then faster and its
treatment more difficult says Bursitis Specialist. In 20 to 30% of cases, a psychological
shock (mourning, rupture ...) is also at the origin of the outbreak of the disease.
Rheumatoid arthritis does not manifest itself in the same way in all patients and its evolution
varies greatly from one profile to another. The treatment has two axes: analgesics, usually
nonsteroidal anti-inflammatory drugs to fight against pain, associated with infiltrations and
sometimes low-dose corticosteroids for the acute phase. In parallel, a background treatment is
also now systematically put in place to interrupt the inflammatory process, a strategy that is
all the more effective if it is initiated early.
Block inflammation
When the disease is identified early, the Bursitis Doctor prescribes metholtrexate, which
remains the reference medicine to block inflammation. If the disease is already advanced or,
after three months, the treatment is insufficient, the doctor can tap into the new arsenal of
biotherapies to find, among the four molecules - soon five - now available, the one to which
the patient will respond best .